Literature DB >> 18226965

Differential Changes in TRPV1 expression after trigeminal sensory nerve injury.

Hyun Yeong Kim1, Chul-Kyu Park, Ik-Hyun Cho, Sung Jun Jung, Joong Soo Kim, Seog Bae Oh.   

Abstract

UNLABELLED: We have recently demonstrated that inferior alveolar nerve and mental nerve (branches of the mandibular nerve) injury from rats serves as a valid trigeminal neuropathic pain model. In these animals, we found that neuronal loss of trigeminal ganglion (TG) was not correlated with pain hypersensitivity. In this study, we examined changes of transient receptor potential vanilloid 1 (TRPV1) expression in the injured and uninjured TG neurons using immunohistochemical analysis at 3 days after surgery, the time point where we observed significant pain hypersensitivity. Injured neurons were identified by positive immunoreactivity for activating transcription factor 3 (ATF3). ATF3 immunoreactivity was exclusively observed in the nuclei of subpopulation of ipsilateral mandibular TG neurons, whereas no ATF3 expression was found in the naive and contralateral TG neurons. Interestingly, the expression of TRPV1 was increased in the uninjured ipsilateral maxillary TG neurons as well as in the uninjured ipsilateral mandibular TG neurons. The upregulation of TRPV1 and ATF3 expression returned to the basal level at 60 days after surgery. Our results demonstrate that trigeminal sensory nerve injury induced differential changes in TRPV1 expression of the injured and uninjured TG neurons. The upregulation of TRPV1 in uninjured TG neurons may play an important role in pain hypersensitivity after trigeminal nerve injury. PERSPECTIVE: The TRPV1 is a well-known pain transducer molecule and plays crucial roles in the perception of inflammatory and thermal pain. This article presents that TRPV1 expression was increased in uninjured neurons rather than injured neurons after peripheral nerve injury. The upregulation of TRPV1 in uninjured neurons may be associated with the development of neuropathic pain. TRPV1 might be a potential target for the treatment of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226965     DOI: 10.1016/j.jpain.2007.11.013

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  27 in total

Review 1.  Capsaicinoids in the treatment of neuropathic pain: a review.

Authors:  John F Peppin; Marco Pappagallo
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

2.  Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord.

Authors:  Carly J McCarthy; Eugenia Tomasella; Mariana Malet; Kim B Seroogy; Tomas Hökfelt; Marcelo J Villar; G F Gebhart; Pablo R Brumovsky
Journal:  Brain Struct Funct       Date:  2015-03-07       Impact factor: 3.270

3.  αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors.

Authors:  Isabel Devesa; Clotilde Ferrándiz-Huertas; Sakthikumar Mathivanan; Christoph Wolf; Rafael Luján; Jean-Pierre Changeux; Antonio Ferrer-Montiel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 4.  Contribution of primary afferent channels to neuropathic pain.

Authors:  Andrea M Harriott; Michael S Gold
Journal:  Curr Pain Headache Rep       Date:  2009-06

5.  Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury.

Authors:  Susan M Carlton; Junhui Du; Huai Yu Tan; Olivera Nesic; Gregory L Hargett; Anne C Bopp; Ammar Yamani; Qing Lin; William D Willis; Claire E Hulsebosch
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

6.  Nerve Growth Factor Regulates Transient Receptor Potential Vanilloid 2 via Extracellular Signal-Regulated Kinase Signaling To Enhance Neurite Outgrowth in Developing Neurons.

Authors:  Matthew R Cohen; William M Johnson; Jennifer M Pilat; Janna Kiselar; Alicia DeFrancesco-Lisowitz; Richard E Zigmond; Vera Y Moiseenkova-Bell
Journal:  Mol Cell Biol       Date:  2015-09-28       Impact factor: 4.272

7.  Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats.

Authors:  Toyokazu Tsuchihara; Sho Ogata; Koichi Nemoto; Takatoshi Okabayashi; Kuniaki Nakanishi; Naoki Kato; Ryuichi Morishita; Yasufumi Kaneda; Maki Uenoyama; Shinya Suzuki; Masatoshi Amako; Toshiaki Kawai; Hiroshi Arino
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

8.  Capsaicin avoidance as a measure of chemical hyperalgesia in orofacial nerve injury models.

Authors:  Yves Boucher; Mirela Iodi Carstens; Carolyn M Sawyer; Karen L Zanotto; Austin W Merrill; E Carstens
Journal:  Neurosci Lett       Date:  2013-04-02       Impact factor: 3.046

9.  Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovács; Christopher N Honda; Myra G Nunez; Alice A Larson
Journal:  J Pain       Date:  2013-11-01       Impact factor: 5.820

Review 10.  Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

Authors:  Christian A von Hehn; Ralf Baron; Clifford J Woolf
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.